Clinical Trials Browser

Unknown × Carcinoma, Hepatocellular × HMPL-013 × Clear all

NCT05971199 2023-08-02

Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular